Xiaoling She

1.6k citations

46 papers · 1.2k indexed · h-index 23

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Oral Surgery top 5%
- Oral and Maxillofacial Pathology

Papers in ⓘ

Molecular Biology 25
- Circular RNAs in diseases 6
Cancer Research 15
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 9

Co-authors: Guiyuan Li (15 shared papers)Minghua Wu (17 shared papers)Guohua Lv (9 shared papers)Ming‐Xiang Zou (8 shared papers)Yi Jiang (7 shared papers)Changhong Liu (9 shared papers)Yingnan Sun (8 shared papers)Peiyao Li (9 shared papers)
Journals: Neurosurgery (3 papers)Journal of Hematology & Oncology (3 papers)Frontiers in Immunology (2 papers)Scientific Reports (1 paper)Phytotherapy Research (1 paper)
Partner nations: China United States Uganda

In The Last Decade

Xiaoling She

42 papers receiving 1.2k citations

Peers

Countries citing papers authored by Xiaoling She

Since Specialization

Citations

This map shows the geographic impact of Xiaoling She's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling She with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling She more than expected).

Fields of papers citing papers by Xiaoling She

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling She. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling She. The network helps show where Xiaoling She may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoling She, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoling She Line = papers co-authored together Xiaoling She links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma Carcinogenesis ·Zhaohui Luo, Yafei Dai, Liyang zhang, Jiang Chen, Zheng Li, Jianbo Yang, James B. McCarthy, Xiaoling She, Wenling Zhang, Jian Ma, Wei Xiong, Minghua Wu, Jianhong Lu, Xiayu Li, Xiaoling Li, Juanjuan Xiang, Guiyuan Li	2012	95
2	Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth Brain Research ·Hailin Tang, Xiaoping Liu, Zeyou Wang, Xiaoling She, Xi Zeng, Min Deng, Qianjin Liao, Xiaofang Guo, Rong Wang, Xiaoling Li, Zeng Fang, Minghua Wu, Guiyuan Li	2011	83
3	A cytoplasmic long noncoding RNA LINC00470 as a new AKT activator to mediate glioblastoma cell autophagy Journal of Hematology & Oncology ·Changhong Liu, Yan Zhang, Xiaoling She, Fan Li, Peiyao Li, Jianbo Feng, Haijuan Fu, Qing Liu, Qiang Liu, Zhao Chun-hua, Yingnan Sun, Minghua Wu	2018	72
4	Serum and Ectopic Endometrium from Women with Endometriosis Modulate Macrophage M1/M2 Polarization via the Smad2/Smad3 Pathway Journal of Immunology Research ·Meifang Nie, Qi Xie, Yahong Wu, Hua He, Lu‐Jie Zou, Xiaoling She, Xianqing Wu	2018	58
5	LINC00470 Coordinates the Epigenetic Regulation of ELFN2 to Distract GBM Cell Autophagy Molecular Therapy ·Changhong Liu, Haijuan Fu, Xiaoping Liu, Qianqian Lei, Yan Zhang, Xiaoling She, Qiang Liu, Qing Liu, Yingnan Sun, Guiyuan Li, Minghua Wu	2018	55
6	Lung microbiome alterations in NSCLC patients Scientific Reports ·Leliang Zheng, Ruizheng Sun, Yinghong Zhu, Zheng Li, Xiaoling She, Xingxing Jian, Fenglei Yu, Xueyu Deng, Buqing Sai, Lujuan Wang, Wen Zhou, Minghua Wu, Guiyuan Li, Jingqun Tang, Wei Jia, Juanjuan Xiang	2021	52
7	miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma Oncology Reports ·Xiaoling She, Zhibin Yu, Yulong Cui, Qianqian Lei, Zeyou Wang, Gang Xu, Juanjuan Xiang, Minghua Wu, Guiyuan Li	2014	52
8	Coagulation Factor X Regulated by CASC2c Recruited Macrophages and Induced M2 Polarization in Glioblastoma Multiforme Frontiers in Immunology ·Yan Zhang, Jianbo Feng, Haijuan Fu, Changhong Liu, Zhibin Yu, Yingnan Sun, Xiaoling She, Peiyao Li, Chunhua Zhao, Yang Liu, Tao Liu, Qiang Liu, Qing Liu, Guiyuan Li, Minghua Wu	2018	51
9	Expression of programmed death-1 ligand (PD-L1) in tumor-infiltrating lymphocytes is associated with favorable spinal chordoma prognosis PubMed ·Ming‐Xiang Zou, An-bo Peng, Guohua Lv, Xiaobin Wang, Jing Li, Xiaoling She, Yi Jiang	2016	51
10	miR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells Medical Oncology ·Xiaoling She, Zhibin Yu, Yulong Cui, Qianqian Lei, Zeyou Wang, Gang Xu, Zhaohui Luo, Guiyuan Li, Minghua Wu	2014	45
11	Clinicopathologic implications of CD8+/Foxp3+ ratio and miR-574-3p/PD-L1 axis in spinal chordoma patients Cancer Immunology Immunotherapy ·Ming‐Xiang Zou, Ke-Miao Guo, Guohua Lv, Wei Huang, Jing Li, Xiaobin Wang, Yi Jiang, Xiaoling She	2017	42
12	Inflammation‐induced S100A8 activates Id3 and promotes colorectal tumorigenesis International Journal of Cancer ·Xuemei Zhang, Feiyan Ai, Xiayu Li, Xiaoling She, Nan Li, Anliu Tang, Zailong Qin, Qiurong Ye, Li Tian, Guiyuan Li, Shourong Shen, Jian Ma	2015	42
13	Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor Neurosurgery ·Ming‐Xiang Zou, Guohua Lv, Xiaobin Wang, Wei Huang, Jing Li, Yi Jiang, Xiaoling She	2018	38
14	Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1α stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment Oncogene ·Jianbo Feng, Yan Zhang, Xiaoling She, Yingnan Sun, Li Fan, Xing Ren, Haijuan Fu, Changhong Liu, Peiyao Li, Zhao Chun-hua, Qiang Liu, Qing Liu, Guiyuan Li, Minghua Wu	2018	38
15	The Relationship Between Tumor-Stroma Ratio, the Immune Microenvironment, and Survival in Patients With Spinal Chordoma Neurosurgery ·Ming‐Xiang Zou, Bo‐Wen Zheng, Fusheng Liu, Xiaobin Wang, Jiarui Hu, Wei Huang, Zhehao Dai, Qian-Shi Zhang, Fu-Bing Liu, Hua Zhong, Yi Jiang, Xiaoling She, Xiaobing Li, Guohua Lv, Jing Li	2019	36
16	Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma Oncotarget ·Yunchao Li, Chunhua Zhao, Zhibin Yu, Jiarui Chen, Xiaoling She, Peiyao Li, Changhong Liu, Yan Zhang, Jianbo Feng, Haijuan Fu, Bing Wang, Lei Kuang, Lei Li, Guohua Lv, Minghua Wu	2016	36
17	Inhibiting CD164 Expression in Colon Cancer Cell Line HCT116 Leads to Reduced Cancer Cell Proliferation, Mobility, and Metastasis in vitro and in vivo Cancer Investigation ·Jingqun Tang, Liyang Zhang, Xiaoling She, Guangqian Zhou, Fenglei Yu, Juanjuan Xiang, Gang Li	2012	34
18	Novel Therapy for Glioblastoma Multiforme by Restoring LRRC4 in Tumor Cells: LRRC4 Inhibits Tumor-Infitrating Regulatory T Cells by Cytokine and Programmed Cell Death 1-Containing Exosomes Frontiers in Immunology ·Peiyao Li, Jianbo Feng, Yang Liu, Qiang Liu, Li Fan, Qing Liu, Xiaoling She, Changhong Liu, Tao Liu, Chunhua Zhao, Wei Wang, Guiyuan Li, Minghua Wu	2017	33
19	The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells Journal of Hematology & Oncology ·Zeyou Wang, Qin Guo, Rong Wang, Gang Xu, Peiyao Li, Yingnan Sun, Xiaoling She, Qiang Liu, Qiong Chen, Zhibin Yu, Changhong Liu, Jing Xiong, Guiyuan Li, Minghua Wu	2016	32
20	A four‐factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma SHILAP Revista de lepidopterología ·Ming‐Xiang Zou, Yue Pan, Wei Huang, Tao‐Lan Zhang, David Escobar, Xiao‐Bin Wang, Yi Jiang, Xiaoling She, Guohua Lv, Jing Li	2020	31

About Xiaoling She

Xiaoling She is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Rheumatology, having authored 46 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (9 papers), Sarcoma Diagnosis and Treatment (7 papers), Circular RNAs in diseases (6 papers), Bone Tumor Diagnosis and Treatments (6 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune cells in cancer (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Cancer Research (579 citations), Oral Surgery (88 citations), Rheumatology (180 citations), Immunology (218 citations) and Molecular Biology (695 citations). Xiaoling She has collaborated with scholars based in China, United States and Uganda. Frequent co-authors include Guiyuan Li, Minghua Wu, Guohua Lv, Ming‐Xiang Zou, Yi Jiang, Changhong Liu, Yingnan Sun, Peiyao Li, Jing Li and Zhibin Yu. Their work appears in journals such as Neurosurgery, Journal of Hematology & Oncology, Frontiers in Immunology, Scientific Reports and Phytotherapy Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact